(0.05%) 5 472.07 points
(0.09%) 39 149 points
(0.36%) 17 782 points
(0.06%) $80.88
(-3.66%) $2.66
(-0.80%) $2 312.20
(0.16%) $28.92
(3.52%) $1 021.10
(0.28%) $0.936
(0.69%) $10.68
(0.44%) $0.792
(-0.27%) $87.25
Live Chart Being Loaded With Signals
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States...
Stats | |
---|---|
今日成交量 | 16 500 |
平均成交量 | 0 |
市值 | 1.14B |
EPS | $-0.170 ( Q3 | 2023-11-06 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.0100 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0190 (41.76%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-11-09 | Casdin Eli | Sell | 755 766 | Earn-out Shares |
2023-11-09 | Casdin Eli | Sell | 5 488 164 | Common Stock |
2023-11-09 | Casdin Eli | Sell | 8 110 001 | Warrants to purchase Class A Common Stock (right to buy) |
2023-11-09 | Casdin Eli | Sell | 101 010 | Stock Option (Right to Buy) |
2023-11-09 | Nallicheri Melanie | Buy | 626 999 | Common Stock |
INSIDER POWER |
---|
-96.90 |
Last 65 transactions |
Buy: 1 747 208 | Sell: 71 082 811 |
音量 相关性
EQRx, Inc. 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
EQRx, Inc. 相关性 - 货币/商品
EQRx, Inc. 财务报表
Annual | 2022 |
营收: | $0 |
毛利润: | $0 (0.00 %) |
EPS: | $0.430 |
FY | 2022 |
营收: | $0 |
毛利润: | $0 (0.00 %) |
EPS: | $0.430 |
FY | 2021 |
营收: | $0.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $0 |
FY | 2020 |
营收: | $0.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $0 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
EQRx, Inc.
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. Its product pipeline in development includes Aumolertinib, an EGFR inhibitor for the treatment of ?EGFR-mutated? non-small cell lung cancer (NSCLC); Sugemalimab, an anti-PD-L1 antibody for the treatment of ?stage III and IV ?NSCLC; Lerociclib, a CDK4/6 inhibitor to treat HR+/HER2- breast cancer; and EQ176, an anti-PD-1?antibody for the treatment of liver cancer. The company has partnerships with Exscientia and AbCellera Biologics Inc. EQRx, Inc. was founded in 2020 and is based in Cambridge, Massachusetts.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。